Lori E Dodd
Overview
Explore the profile of Lori E Dodd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
7774
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bonnett T, Potter G, Dodd L
Clin Trials
. 2025 Feb;
:17407745251313928.
PMID: 39921419
Background: Platform trials typically feature a shared control arm and multiple experimental treatment arms. Staggered entry and exit of arms splits the control group into two cohorts: those randomized during...
2.
Malherbe S, Chen R, Yu X, Smith B, Liu X, Gao J, et al.
medRxiv
. 2025 Jan;
PMID: 39802795
Six months of chemotherapy using current agents is standard of care for pulmonary, drug-sensitive tuberculosis (TB), even though some are believed to be cured more rapidly and others require longer...
3.
4.
Sereti I, Shaw-Saliba K, Dodd L, Dewar R, Laverdure S, Brown S, et al.
PLoS One
. 2024 Nov;
19(11):e0314048.
PMID: 39541305
[This corrects the article DOI: 10.1371/journal.pone.0273914.].
5.
Yarahmadi A, Dodd L, Jaki T, Horby P, Stallard N
Stat Med
. 2024 Aug;
43(24):4667-4683.
PMID: 39165101
Motivated by the experience of COVID-19 trials, we consider clinical trials in the setting of an emerging disease in which the uncertainty of natural disease course and potential treatment effects...
6.
7.
Singh K, Rubenstein K, Callier V, Shaw-Saliba K, Rupert A, Dewar R, et al.
J Infect Dis
. 2024 Apr;
230(3):624-634.
PMID: 38657001
Background: Although antivirals remain important for the treatment COVID-19, methods to assess treatment efficacy are lacking. Here, we investigated the impact of remdesivir on viral dynamics and their contribution to...
8.
Dodd L, Lane H, Muyembe-Tamfum J
NEJM Evid
. 2024 Feb;
3(3):EVIDe2300348.
PMID: 38411453
In 1970, the first case of mpox (formerly known as monkeypox) was documented in an infant in Equateur Province, Democratic Republic of Congo (DRC). Infections with clade I monkeypox virus...
9.
Paules C, Wang J, Tomashek K, Bonnett T, Singh K, Marconi V, et al.
Ann Intern Med
. 2024 Feb;
177(3):343-352.
PMID: 38408357
Background: The ACTT risk profile, which was developed from ACTT-1 (Adaptive COVID-19 Treatment Trial-1), demonstrated that hospitalized patients with COVID-19 in the high-risk quartile (characterized by low absolute lymphocyte count...
10.
Hughes E, Takvorian K, Dodd L, Koscal N, Muller D, Vining T, et al.
NEJM Evid
. 2024 Feb;
1(9):EVIDstat2200228.
PMID: 38319791
Subgroup Analyses: Subpar or Sublime?This animated video explores some of the potential pitfalls of performing subgroup analyses in randomized controlled trials and explains how to approach potential findings with caution.